Xerostomia (Dry Mouth) Therapeutics Market To Witness Enhanced Growth Due To Rising Preference For Prescription Drugs And Growing Prevalence of HIV & Cancer Till 2025 | Million Insights

Xerostomia (Dry Mouth) Therapeutics Market To Witness Enhanced Growth Due To Rising Preference For Prescription Drugs And Growing Prevalence of HIV & Cancer Till 2025 | Million Insights

“Million Insights – World’s Fastest Growing Market Research Database”
According to new report available with Million Insights, the xerostomia therapeutics industry is estimated to grow at a CAGR of 3.2% over the forecast period as the scope and its applications are rising enormously across the globe.

The global Xerostomia (Dry Mouth) Therapeutics Market is anticipated to reach USD 796.1 million and is anticipated to grow at a CAGR of 3.2% in the years to come. Xerostomia is a clinical condition of dry mouth and does not show the signs of hyposalivation and symptoms on frequent terms. This condition is observed when the rate of saliva flow is low in comparison with absorption across the oral mucosa coupled with rate of fluid evaporation from the mouth.

Prolonged xerostomia is a significant disease in patients since it affects speech, chewing, denture-wearing, and swallowing activities. The defined causes of hyposalivation and xerostomia are the use of several medications such as antidepressants, anticoagulants, antiretroviral, hypoglycemics, multivitamins and supplements, and anti-inflammatory drugs. Prevalence of xerostomia persists in a large population with different age groups despite following medical or dental consultation.

Full Research Report On Global Xerostomia (Dry Mouth) Therapeutics Market Analysis available at: https://www.millioninsights.com/industry-reports/xerostomia-dry-mouth-therapeutics-market

Rise in use of prescribed medication coupled with rising prevalence of HIV and cancer are expected to act as primary drivers for market growth. Secondary factors such as easy availability of cost-effective medications along with rise in preference for prescription drugs act as market drivers. In addition, rising cases of depression, Parkinson’s disease, HIV, and hypertension are also expected to contribute significantly to the market development. The market is further triggered by rise in cases of chronic xerostomia due to intake of certain medications. However, significant costs and uneven medical infrastructure are likely to hinder the market growth in the forecast period upto 2025.

Xerostomia (Dry mouth) therapeutics market is segmented into type, product, and region. Type category includes prescription and OTC. “Over-the-counter (OTC)” segment accounts for a larger share and is expected to gain significant momentum in the forecast period owing to wide variety & availability of branded drugs and low-cost products. Product segmentation includes salivary substitutes, salivary stimulants, and dentrifices. Dentrifices segment accounted for a significant market share owing to effectiveness, affordability and higher adoption. Geographic segmentation for xerostomia (dry mouth) therapeutics industry includes North America, South America, Europe, Asia-Pacific, Middle East and Africa.

Asia-Pacific’s xerostomia therapeutics market is anticipated to rise at a CAGR of 4.2% in the forthcoming period due to rising awareness, high prevalence of Parkinson’s disease, cancer and HIV. North America followed by Europe accounts for a higher revenue share owing to rising prevalence of xerostomia and other dry mouth diseases such as rheumatoid arthritis, Sjogren’s syndrome and HIV along with rising awareness by government and health care NGOs.

The key players in the xerostomia (dry mouth) therapeutics market include GlaxoSmithKline plc; Church & Dwight Co., Inc.; Colgate-Palmolive Company; Hikma Pharmaceuticals PLC; Pendopharm; Sun Pharmaceuticals Industries Ltd.; Lupin Pharmaceuticals, Inc.; Pfizer, Inc.; Parnell Pharmaceuticals, Inc.; Acacia Pharma; and OraCoat.

Request for Free Sample Copy at: https://www.millioninsights.com/industry-reports/xerostomia-dry-mouth-therapeutics-market/request-sample

Market Segment:

Type Outlook (Market Revenue in USD Million, 2014 – 2025)
    • OTC
    • Prescription

Product Outlook (Market Revenue in USD Million, 2014 – 2025)
    • Salivary Stimulants
    • Salivary Substitutes
    • Dentifrices

Regional Outlook (Revenue, USD Million, 2014 – 2025)
    • North America
        • U.S.
        • Canada
    • Europe
        • Germany
        • UK
    • Asia Pacific
        • China
        • Japan
        • India
    • Latin America
        • Brazil
        • Mexico
    • Middle East & Africa
        • South Africa

Related Reports of this Category available at Million Insights: https://www.millioninsights.com/industry/healthcare

About Million Insights

Million Insights, is a distributor of market research reports, published by premium publishers only. We have a comprehensive market place that will enable you to compare data points, before you make a purchase. Enabling informed buying is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store, includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.

For More Information: www.millioninsights.com

Media Contact
Company Name: Million Insights
Contact Person: Ryan Manuel
Email: Send Email
Phone: 91-20-65300184
Address:Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar
City: Pune
State: Maharashtra
Country: India
Website: www.millioninsights.com/industry-reports/xerostomia-dry-mouth-therapeutics-market